Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04075279
Other study ID # STUDY19050097
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 17, 2019
Est. completion date July 24, 2020

Study information

Verified date April 2021
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an observational study to examine the cardiovascular mechanisms of increased cardiovascular mortality in those with high activity occupations.


Description:

The current proposal uses a repeated-measures, within-subject design to address our aims. Twenty male participants will report to the laboratory to provide informed consent, complete baseline assessments, and receive ambulatory monitors. Following this session, each participant will wear physical activity and ambulatory cardiovascular monitors for 7 days, including at least one non-work day and one work day. Characterization of work activity will use physical activity data from self-reported time at work (Specific Aim I). The 24-hour cardiovascular load (HR and BP) and nocturnal HRV will be compared across work and non-work days (Specific Aim II). Lastly, whether fitness level or job strain modify the difference in cardiovascular strain between work vs. non-work days will be evaluated (Specific Aim III).


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date July 24, 2020
Est. primary completion date April 20, 2020
Accepts healthy volunteers
Gender Male
Age group 35 Years to 59 Years
Eligibility Inclusion Criteria: - middle age (35-59 years) - male - self-report working full-time in the food service industry (=30 hours/week) - self-report predominantly completing light intensity activity job responsibilities (=75% work time walking, light movement, or standing) Exclusion Criteria: - Resting blood pressure of =150 mmHg systolic and/or =95 mmHg diastolic - currently taking medications that are known to affect blood pressure or heart rate (e.g. Beta-blockers, ACE inhibitors, etc.) - greater than low risk to participate in physical activity as determined by PAR-Q (answer of yes to any of the 7 physical activity readiness questionnaire questions) - report working a second job in addition to their primary full-time job - report working overnight shifts (10pm-6am) - reported physical dysfunction (inability to walk 2 city blocks or climb 2 flights of stairs) - inability to complete the sub-maximal exercise test to completion (80% age-predicted heart rate maximum) - Currently being treated for a serious medical condition such as kidney disease, liver disease, cancer, or heart disease.

Study Design


Locations

Country Name City State
United States Physical Activity and Weight Management Research Laboratory Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 24-hour Heart Rate We will calculate the average heart rate over each 24 hour period throughout a one week monitoring period. 24 hours
Secondary 24-hour Ambulatory Systolic Blood Pressure We will calculate the average systolic blood pressure over a 24-hour period on two separate days (workdays versus non-workdays). 24 hours
Secondary Nocturnal Heart Rate Variability, RMSSD We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is root mean square successive differences (RMSSD). approximately 8 hours (sleep time)
Secondary Physical Activity Pattern. Steps Per Day This physical activity metric of steps per day was calculated as average number of steps during each day type (work versus non-workdays) throughout one week 1 week
Secondary Nocturnal Heart Rate Variability, SDNN We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is standard deviation of the normal to normal RR intervals (SDNN). approximately 8 hours (sleep time)
Secondary Nocturnal Heart Rate Variability, LF We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is low frequency power (LF). approximately 8 hours (sleep time)
Secondary Nocturnal Heart Rate Variability, HF We will calculate the average heart rate variability during each night's sleep for a total of one week. The specific HRV variable presented is high frequency power (HF). approximately 8 hours (sleep time)
Secondary Physical Activity Pattern. MVPA This physical activity metric of minutes of moderate to vigorous physical activity was calculated as average minutes during each day type (work versus non-workdays) throughout one week 1 week
Secondary Physical Activity Pattern. LPA This physical activity metric of minutes of light physical activity was calculated as average minutes during each day type (work versus non-workdays) throughout one week 1 week
Secondary Physical Activity Pattern. Sedentary This physical activity metric of minutes of sedentary time was calculated as average minutes during each day type (work versus non-workdays) throughout one week 1 week
Secondary Physical Activity Pattern. Upright This physical activity metric of minutes of upright time was calculated as average minutes during each day type (work versus non-workdays) throughout one week 1 week
Secondary 24-hour Ambulatory Diastolic Blood Pressure We will calculate the average diastolic blood pressure over a 24-hour period on two separate days (workdays versus non-workdays). 24 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)